Events

Recall of Device Recall Symbiq TwoChannel Infuser

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Hospira Inc..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    63993
  • Event Risk Class
    Class 2
  • Event Number
    Z-0354-2017
  • Event Initiated Date
    2013-02-05
  • Event Status
    Terminated
  • Event Country
    United States
  • Event Terminated Date
    2016-12-15
  • Event Source
    USFDA
  • Event Source URL
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=115184
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
    Pump, infusion - Product Code FRN
  • Reason
    Hospira has received reports of malfunction s205 backup battery failure alarms in symbiq v3.13 pumps. this issue to an incorrect installation of components on some of the power supply controller (psc) boards distributed prior to september 2012. on pumps where incorrect installation of components has occurred, the backup battery power discharges and subsequently, the battery cannot be charged. because of the battery depletion, or lack of charge, a visual and audible warning alarm, s205, is displayed. an s205 alarm is intended to notify the customer that the coin call battery, powering the backup buzzer, may need to be charged or replaced.
  • Action
    Hospira sent an Urgent Field Device Correction letter dated Feburay 5, 2013, to all affected customers. Hospira has implemented a correction to the manufacturing process to address this issue. Symbiq v3.13 pumps that have been shipped from Hospira since September 2012 and pumps that were upgraded to v3.13 in the Field after September 2012 are not impacted by this issue. If you are unsure of when you were shipped Symbiq v3.13 pumps or when your devices were upgraded, contact Hospira. Please complete the attached reply form and return it via fax number or e-mail address on the form, even if you do not currently have the impacted infuser. lease contact Stericycle at 1-866-201-9072 (M-F, Bam - 5pm EST) to obtain additional copies of the reply form. If you have further distributed these devices, please notify your accounts who may have received these infusers from you and ask them to contact Stericycle at 1-866-201-9072 (M-F, 8am- 5pm EST) to receive a reply form.

Device

Device Recall Symbiq TwoChannel Infuser
  • Model / Serial
  • Product Classification
    General Hospital and Personal Use Devices
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    Nationwide Distribution and Canada
  • Product Description
    Symbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids; Product List Number 16027
  • Manufacturer
    Hospira Inc.

Manufacturer

Hospira Inc.
  • Manufacturer Address
    Hospira Inc., 275 N Field Dr, Lake Forest IL 60045-2579
  • Manufacturer Parent Company (2017)
    Pfizer
  • Source
    USFDA